A finger-prick blood test can accurately identify p-tau217 — a key biomarker of Alzheimer's disease (AD) — without the need for temperature or storage control measures. In a pilot study, researchers ...

AUSTIN, TX / ACCESS Newswire / March 31, 2026 / BetterWay™ blood testing by Babson Diagnostics, a science-first healthcare technology company transforming diagnostic blood testing, today announced a ...

Longtime partners in simplifying blood sample collection and testing, BD and Babson Diagnostics are now making their miniaturized approach available to healthcare providers after years of development.

The company that aims to succeed where Theranos failed just achieved a critical milestone ahead of bringing its BetterWay blood testing service to market next year. FDA recently cleared the BD ...

Please provide your email address to receive an email when new articles are posted on . The BD MiniDraw device is part of a blood testing collection system that is designed to make routine blood tests ...

Modern blood testing is the foundation of clinical screening and decision-making. Timely disease diagnosis, prevention and chronic care management depend on accurate diagnostic testing. More than 7 ...

In some embodiments, the method comprises providing a first low volume, capillary blood sample (or any low volume blood sample and/or any blood sample not obtained from a vein or by venipuncture) ...

Hims & Hers Health, Inc. (NYSE: HIMS) on Wednesday agreed to acquire YourBio Health, Inc., a Boston-based provider of capillary whole blood sampling technology. YourBio Health develops technologies ...